GLAXO — GlaxoSmithKline Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- IN₹407.37bn
- IN₹379.49bn
- IN₹38.22bn
Brief: Glaxosmithkline Pharma Q1 Consol Profit 2.37 Billion Rupees
Brief: Glaxosmithkline Pharmaceuticals: Receives Demand Notice From National Pharmaceutical Pricing Authority
India's GlaxoSmithKline Pharma gains after Q4 profit rise; PT hike
Brief: Glaxosmithkline Pharmaceuticals March-Quarter Consol Profit 2.78 Billion Rupees
India's Cipla jumps on FDA approval for Ventolin HFA generic inhaler
Brief: Glaxosmithkline Pharmaceuticals Receives TDS Demand Liability Of 20.1 Million Rupees
Brief: Glaxosmithkline Pharmaceuticals Ltd Receives Final Order With Tax Demand Liability Of 232.1 Mln Rupees For AY 2023-24
Brief: Glaxosmithkline Pharmaceuticals Ltd Says Juby Chandy Resigns As Whole-Time Director And CFO
Brief: GlaxoSmithKline Pharmaceuticals Says Ronojit Biswas Appointed As Whole-Time Director & CFO
Brief: Glaxosmithkline Pharmaceuticals Gets Order With Total Tax Demand Of 37.9 Million Rupees Including Tax, Penalty
Brief: Glaxosmithkline Pharmaceuticals Ltd Dec-Quarter Consol Profit 2.96 Billion Rupees
Brief: Glaxosmithkline Pharmaceuticals Gets Tax Demand Of 85.7 Million Rupees
Brief: Glaxosmithkline Pharmaceuticals Ltd Receives Tax Demand Order Of 9 Million Rupees
Brief: Glaxosmithkline Pharmaceuticals Receives Tax Demand For 5.3 Million Rupees Including Penalty
GlaxoSmithKline India reports higher second-quarter profit on specialty medicine growth
Brief: Glaxosmithkline Pharma Q2 Consol Profit 2.57 Billion Rupees
Brief: Glaxosmithkline Pharmaceuticals Gets Tax Demand Of Total 18.1 Million Rupees
India's GlaxoSmithKline Pharma rises on entering country's oncology market
India's GlaxoSmithKline Pharma on course for sharpest fall in 5 years on revenue drop